Provided by Tiger Trade Technology Pte. Ltd.

Anika Therapeutics

19.10
-0.2600-1.34%
Post-market: 19.100.00000.00%19:30 EDT
Volume:92.26K
Turnover:1.77M
Market Cap:255.61M
PE:-68.94
High:19.47
Open:19.41
Low:19.01
Close:19.36
52wk High:22.88
52wk Low:8.67
Shares:13.38M
Float Shares:11.29M
Volume Ratio:0.86
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2770
EPS(LYR):-0.7628
ROE:-2.19%
ROA:-0.87%
PB:1.86
PE(LYR):-25.04

Loading ...

Anika Therapeutics Amends Bank of America Revolving Credit Facility, Extends Maturity to 2031

Reuters
·
Jul 15

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 06

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 06

Anika Therapeutics Signals Momentum Amid Regulatory Risks

TIPRANKS
·
May 20

Anika Therapeutics Director John B. Henneman III acquires 5,000 shares for $73,319.50

Reuters
·
May 04

Top Executive Makes Bold Insider Move at Anika Therapeutics

TIPRANKS
·
May 01

Anika CEO Stephen Griffin buys $149,881 common shares

Reuters
·
May 01

TELA Bio Inc - Prelim Q1 2026 Revenue Approx $19.0 Mln Versus Guidance of $18.5 Mln

THOMSON REUTERS
·
May 01

TELA Bio Inc - Joseph Capper to Be Nominated as Director and Expected to Serve as Chair

THOMSON REUTERS
·
May 01

TELA Bio Inc - Chairman Doug Evans, Kurt Azarbarzin, Vince Burgess, Federica O’brien to Depart Board

THOMSON REUTERS
·
May 01

Anika Therapeutics announces annual shareholder meeting webcast

Reuters
·
May 01

Anika Therapeutics publishes 2025 annual report on Form 10-K

Reuters
·
May 01

Anika Therapeutics Signals Momentum Amid Regulatory Hurdles

TIPRANKS
·
Apr 30

Anika Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 29

Anika Therapeutics Posts Strong Q1 2026 Revenue Growth

TIPRANKS
·
Apr 29

Anika Therapeutics Q1 revenue rises 13%

Reuters
·
Apr 29

Anika Q1 operating loss widens to $5.49 million; revenue rises 13% to $29.6 million

Reuters
·
Apr 29

Anika Therapeutics Inc: Maintaining Previously Provided 2026 Guidance

THOMSON REUTERS
·
Apr 29

Anika Therapeutics Q1 Pretax Profit USD -4.821 Million

THOMSON REUTERS
·
Apr 29

Anika Therapeutics Q1 Income From Operations USD -5.488 Million

THOMSON REUTERS
·
Apr 29